In addition, BPTES was referred to inhibit only GLS1 and CB-839 was referred to inhibit both GLS 1 and 2 [165,168] These results suggest a possible application of glutaminolysis inhibitors for EMT suppression in cancer cells with underlying molecular events by the treatment. This evidence concerns the gene GLS and cancer.